Disclosure in Publications, Presentations, etc.

Financial disclosures in publications, presentations, etc. allows readers, reviewers and colleagues to evaluate best serves the scientific community and the public.  In addition, many scientific journals and funding agencies require authors disclose related financial interests to improve the integrity of the science and manage financial conflicts of interest. Full disclosure allows readers to form their own opinions on whether a financial conflict of interest exists and what relevance it may have to the study.

UCI's standard practice requires researchers reviewed by the COIOC to disclose their financial interests in the publications and presentations related to that COIOC reviewed research project to promote transparency. The Disclosing Individual is required to embed a financial interest disclosure in the text of the publication, either in the footnotes or in the acknowledgement section, whether or not such disclosure is or is not also required by the journal. Similarly, the COIOC requires researchers to include a financial disclosure slide in all presentations and disclosure language on all posters based on the COIOC reviewed research project. In general, when publicly sharing information regarding a COIOC reviewed research project whether through publications, presentations, etc., the Disclosing Individual should disclose their reviewed related financial interest to promote transparency.

The following are examples of how a financial interest with an outside entity should be disclosed in publications of research results:

Example #1:

These studies were supported by a grant from NIH (Award #________________). Joe Doe has an equity interest in XYZ, Inc., a company that may potentially benefit from the research results, and also serves on the company's Scientific Advisory Board. John Doe's relationship with XYZ, Inc. has been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies.

Example #2:

Dr. John Doe receives research funding from XYZ, Inc., which is developing products related to the research described in this paper. In addition, the author serves as a consultant to XYZ, Inc., and receives compensation for these services. John Doe's relationship with XYZ, Inc. has been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies.

Example #3:

The University of California, Irvine has a financial [ownership] interest in X Biotech, the company sponsoring this research. Jane Doe and the University of California, Irvine may potentially benefit from this research. Jane Doe has received honoraria from X Biotech.  Jane Doe's relationship with X Biotech has been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies.

Example #4:

These studies were supported by a grant from the NSF (Grant #________________). Principal Investigator _______________ has an equity interest in XYZ, Inc. ____'s relationship with XYZ, Inc. has been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies.

Please Note: In addition to the guidelines stated above, journals have different standards about publishing financial relationships. For additional examples on how to incorporate such language, access guidance from the International Committee of Medical Journals Editors and the American Chemical Society Publications.